Skip to content

Progyny PGNY Treasury Stock

Treasury Stock at other companies

CVS Health logo
CVS HealthCVS
$36.71B-0.1%
Voya Financial logo
Voya FinancialVOYA
$1.19B+50.8%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$1.1B+47.5%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$43.52B-0.2%

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.11B-27.1%

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's treasury stock?
Progyny (PGNY) reported treasury stock of $505.76M in Q1 2026.
How has Progyny's treasury stock changed year-over-year?
Progyny's treasury stock increased by 66.4% year-over-year, from $303.89M to $505.76M.
What is the long-term trend for Progyny's treasury stock?
Over 5 years (2020 to 2025), Progyny's treasury stock has grown at a 228.9% compound annual growth rate (CAGR), from $1.01M to $388.08M.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.